BNP Paribas Financial Markets’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
60,213
+17,941
+42% +$396K ﹤0.01% 2949
2026
Q1
$618K Buy
42,272
+5,199
+14% +$76.3K ﹤0.01% 3471
2025
Q4
$469K Sell
37,073
-187,968
-84% -$2.77M ﹤0.01% 3603
2025
Q3
$3.46M Buy
225,041
+208,368
+1,250% +$3.36M ﹤0.01% 2230
2025
Q2
$262K Buy
16,673
+5,327
+47% +$80.8K ﹤0.01% 3674
2025
Q1
$217K Sell
11,346
-10,794
-49% -$236K ﹤0.01% 3644
2024
Q4
$528K Buy
+22,140
New +$618K ﹤0.01% 3262

Other funds holding RXO

BNP Paribas Financial Markets's RXO Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its RXO (RXO) stake by 42% in Q2 2026, buying an estimated $396K and bringing the position to 60,213 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

BNP Paribas Financial Markets first reported a position in RXO in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.46M in Q3 2025. 286 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • BNP Paribas Financial Markets held 60,213 shares of RXO worth $1.66M as of Q2 2026.
  • BNP Paribas Financial Markets bought 17,941 RXO shares in Q2 2026, an estimated $396K.
  • RXO made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2949 holding.
  • BNP Paribas Financial Markets first reported a position in RXO in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's RXO position peaked at $3.46M in Q3 2025.
  • 286 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.